Capillary electrophoresis for screening of 20S proteasome inhibitors

Analytical Biochemistry

Volumn 394, Issue 1, 2009, Pages 62-67

  Chen, Wenjing ^a   Mou, Ke ^a   Xu, Bo ^b   Ling, Xiaomei ^a   Cui, Jingrong ^b   Xu, Ping ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

20S proteasome; CE; Enzyme inhibitor; MG115; MG132; Peptidyl vinyl ester

Indexed keywords

CAPILLARY ELECTROPHORESIS; CERIUM; DIMETHYL SULFOXIDE; ESTERS; PROTEINS;

ENZYME INHIBITORS; MG115; MG132; PROTEASOMES; VINYL ESTERS;

FUSED SILICA;

4 (2 HYDROXYETHYL) 1 PIPERAZINEETHANESULFONIC ACID; ALDEHYDE DERIVATIVE; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BUFFER; DIMETHYL SULFOXIDE; ESTER DERIVATIVE; MG 115; PROTEASOME; PROTEASOME INHIBITOR; PROTEINASE INHIBITOR; SILICON DIOXIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; XP 10; XP 11; XP 12; XP 13; XP 14; XP 15; XP 16; XP 17; XP 18; XP 19; XP 20; XP 21; XP 22; XP 32; XP 35; XP 7; XP 8; XP 9;

ARTICLE; CAPILLARY ELECTROPHORESIS; CONTROLLED STUDY; DRUG SCREENING; DRUG STRUCTURE; ELECTRIC POTENTIAL; ENZYME INHIBITION; IC 50; NONHUMAN; PH MEASUREMENT; PRESSURE MEASUREMENT; PRIORITY JOURNAL; PROCESS OPTIMIZATION; RELIABILITY; SIGNAL DETECTION; STRUCTURE ANALYSIS;

EID: 69249206535     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2009.07.020     Document Type: Article

References (35)

1. Cortes J., Thomas D., Koller C., Giles F., Estey E., Faderl S., Garcia-Manero G., McConkey D., Ruiz S.L., Guerciolini R., Wright J., and Kantarjian H. Phase I study of bortezomib in refractory or relapsed acute leukemias. Clin. Cancer Res. 10 (2004) 3371-3376
2. Sprangers R., Li X.M., Mao X.L., Rubinstein J.L., Schimmer A.D., and Kay L.E. TROSY-based NMR evidence for a novel class of 20S proteasome inhibitors. Biochemistry 47 (2008) 6728-6734
3. Tofaris G.K., Layfield R., and Spillantini M.G. α-Synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome. FEBS Lett. 509 (2001) 22-26
4. Moore B.S., Eustáquio A.S., and McGlinchey R.P. Advances in and applications of proteasome inhibitors. Curr. Opin. Chem. Biol. 12 (2008) 434-440
5. Groll M., Ditzel L., L€owe J., Stock D., Bochtler M., Bartunik H.D., and Huber R. Structure of 20S proteasome from yeast at 24 Å resolution. Nature 386 (1997) 463-471
6. Adams J. The development of proteasome inhibitors as anticancer drugs. Cancer Cell 5 (2004) 417-421
7. Vinitsky A., Cardozo C., Sepp-Lorenzino L., Michaud C., and Orlowski M. Inhibition of the proteolytic activity of the multicatalytic proteinase complex (proteasome) by substrate-related peptidyl aldehydes. J. Biol. Chem. 269 (1994) 29860-29866
8. Lynas J.F., Harriott P., Healy A., McKervey M.A., and Walker B. Inhibitors of the chymotrypsin-like activity of proteasome based on di- and tri-peptidyl α-keto aldehydes (glyoxals). Bioorg. Med. Chem. Lett. 8 (1998) 373-378
9. Chatterjee S., Dunn D., Mallya S., and Ator M.A. P′-extended α-ketoamide inhibitors of proteasome. Bioorg. Med. Chem. Lett. 9 (1999) 2603-2606
10. Wu S., Waugh W., and Stella V.J. Degradation pathways of a peptide boronic acid derivative, 2-Pyz-(CO)-Phe-Leu-B(OH)2. J. Pharm. Sci. 89 (2000) 758-765
11. Wu Y.L., Han B., Luo H.Y., Shi G.X., and Wu J.P. Dipeptide boronic acid, a novel proteasome inhibitor, prevents islet-allograft rejection. Transplantation 78 (2004) 360-366
12. Elfsson M., Splittgerber U., Myung J., Mohan R., and Crews C.M. Towards subunit-specific proteasome inhibitors: synthesis and evaluation of peptide α′,β′-epoxyketones. Chem. Biol. 6 (1999) 811-822
13. García-Echeverría C., Imbach P., France D., Fu{combining double acute accent}rst P., Lang M., Noorani M., Scholz D., Zimmermanna J., and Fureta P. A new structural class of selective and non-covalent inhibitors of the chymotrypsin-like activity of the 20S proteasome. Bioorg. Med. Chem. Lett. 11 (2001) 1317-1319
14. Chen P., and Hochstrasser M. Autocatalytic subunit processing couples active site formation in the 20S proteasome to completion of assembly. Cell 86 (1996) 961-972
15. Rock K.L., Gramm C., Rothstein L., Clark K., Stein R., Dick L., Hwang D., and Goldberg A.L. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78 (1994) 761-771
16. Heinemeyer W., Fischer M., Krimmer T., Stachon U., and Wolf D.H. The active sites of the eukaryotic 20S proteasome and their involvement in subunit precursor processing. J. Biol. Chem. 272 (1997) 25200-25209
17. Adams J., Behnke M., Chen S., Cruickshank A.A., Dick L.R., Grenier L., Klunder J.M., Ma Y.T., Plamonda L., and Stein R.L. Potent and selective inhibitors of the proteasome: dipeptidyl boronic acids. Bioorg. Med. Chem. Lett. 8 (1998) 333-338
18. Woods A.K., and Storey K.B. Vertebrate freezing survival: regulation of the multicatalytic proteinase complex and controls on protein degradation. Biochim. Biophys. Acta 1760 (2006) 395-403
19. Zimmerman M., Yurewicz E., and Patel G. A new fluorogenic substrate for chymotrypsin. Anal. Biochem. 70 (1976) 258-262
20. Powers J.C., Asgian J.L., Ekici O.D., and James K.E. Irreversible inhibitors of serine, cysteine, and threonine proteases. Chem. Rev. 102 (2002) 4639-4750
21. Mou K., Xu B., Ma C., Yang X.M., Zou X.M., Lü Y., and Xu P. Novel CADD-based peptidyl vinyl ester derivatives as potential proteasome inhibitors. Bioorg. Med. Chem. Lett. 18 (2008) 2198-2202
22. Huck C.W., Stecher G., Bakry R., and Bonn G.K. Recent progress in high-performance capillary bioseparations. Electrophoresis 24 (2003) 3977-3997
23. Zhang J., Thanh-Ha P.T., Lou Y.J., Hoogmartens J., and Schepdael A.V. Kinetic study of cytochrome P450 3A4 activity on warfarin by capillary electrophoresis with fluorescence detection. J. Chromatogr. A 1082 (2005) 235-239
24. Zhang J., Thanh-Ha P.T., Lou Y.J., Hoogmartens J., and Schepdael A.V. Kinetic study of CYP3A4 activity on verapamil by capillary electrophoresis. J. Pharm. Biomed. Anal. 39 (2005) 612-617
25. Yuan J.P., Yin J.Y., and Wang E.K. Characterization of procaine metabolism as probe for the butyrylcholinesterase enzyme investigation by simultaneous determination of procaine and its metabolite using capillary electrophoresis with electrochemiluminescence detection. J. Chromatogr. A 1154 (2007) 368-372
26. Cai S., Mukherjee J., Tillekeratne L.M.V., Hudson R.A., and Kirchhoff J.R. Inhibition of choline transport by redox-active cholinomimetic bis-catechol reagents. Bioorg. Med. Chem. 15 (2007) 7042-7047
27. Chichester K.D., Sebastian M., Ammerman J.W., and Colyer C.L. Enzymatic assay of marine bacterial phosphatases by capillary electrophoresis with laser-induced fluorescence detection. Electrophoresis 29 (2008) 3810-3816
28. Tan Y., Sun L., Xi Z., Yang G.F., Jiang D.Q., Yan X.P., Yang X., and Li H.Y. A capillary electrophoresis assay for recombinant Bacillus subtilis protoporphyrinogen oxidase. Anal. Biochem. 383 (2008) 200-204
29. Alper B.J., and Schmidt W.K. A capillary electrophoresis method for evaluation of Aβ proteolysis in vitro. J. Neurosci. Methods 178 (2009) 40-45
30. Fan Y., Ludewig R., and Scriba G.K.E. 9-Fluorenylmethoxycarbonyl-labeled peptides as substrates in a capillary electrophoresis-based assay for sirtuin enzymes. Anal. Biochem. 387 (2009) 243-248
31. Whisnan A.R., and Gilman S.D. Studies of reversible inhibition, irreversible inhibition, and activation of alkaline phosphatase by capillary electrophoresis. Anal. Biochem. 307 (2002) 226-234
32. Belenky A., Hughes D., Korneev A., and Dunayevskiy Y. Capillary electrophoretic approach to screen for enzyme inhibitors in natural extracts. J. Chromatogr. A 1053 (2004) 247-251
33. Rodgers K.J., and Dean R.T. Assessment of proteasome activity in cell lysates and tissue homogenates using peptide substrates. Intl. J. Biochem. Cell Biol. 35 (2003) 716-727
34. Mellgren R.L. Specificities of cell permeant peptidyl inhibitors for the proteinase activities of μ-calpain and the 20S proteasome. J. Biol. Chem. 272 (1997) 29899-29903
35. Braun H.A., Umbreen S., Groll M., Kuckelkorn U., Mlynarczuk I., Wigand M.E., Drung I., Kloetzel P.M., and Schmidt B. Tripeptide mimetics inhibit the 20S proteasome by covalent bonding to the active threonines. J. Biol. Chem. 280 (2005) 28394-28411